Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 2017; Volume 92,Issue 3

Special Section on Molecular Pharmacology in China

  • You have access
    A Chinese Perspective on Receptors and Receptor Regulation
    Zijian Li
    Molecular Pharmacology September 2017, 92 (3) 185-187; DOI: https://doi.org/10.1124/mol.117.109587
  • You have access
    Progress in Pharmacological Sciences in China
    Jian-Cheng Wang, Yuangui Zhu, Lei Wu and Erdan Dong
    Molecular Pharmacology September 2017, 92 (3) 188-192; DOI: https://doi.org/10.1124/mol.116.108167
  • You have access
    The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases
    Gongxin Wang and KeWei Wang
    Molecular Pharmacology September 2017, 92 (3) 193-200; DOI: https://doi.org/10.1124/mol.116.107946
  • Open Access
    Phosphorylation of G Protein-Coupled Receptors: From the Barcode Hypothesis to the Flute Model
    Zhao Yang, Fan Yang, Daolai Zhang, Zhixin Liu, Amy Lin, Chuan Liu, Peng Xiao, Xiao Yu and Jin-Peng Sun
    Molecular Pharmacology September 2017, 92 (3) 201-210; DOI: https://doi.org/10.1124/mol.116.107839
  • Open Access
    MG53: Biological Function and Potential as a Therapeutic Target
    Yan Zhang, Hong-Kun Wu, Fengxiang Lv and Rui-Ping Xiao
    Molecular Pharmacology September 2017, 92 (3) 211-218; DOI: https://doi.org/10.1124/mol.117.108241
  • You have access
    Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations for Improved Tumor Therapy
    Hao Qin, Yanping Ding, Ayeesha Mujeeb, Ying Zhao and Guangjun Nie
    Molecular Pharmacology September 2017, 92 (3) 219-231; DOI: https://doi.org/10.1124/mol.116.108084
  • You have access
    Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives
    Tong Wu, Bin Cheng and Liwu Fu
    Molecular Pharmacology September 2017, 92 (3) 232-239; DOI: https://doi.org/10.1124/mol.116.108142
  • You have access
    The Emerging Role of Cables1 in Cancer and Other Diseases
    Jia-Rong Huang, Guang-Mou Tan, Yong Li and Zhi Shi
    Molecular Pharmacology September 2017, 92 (3) 240-245; DOI: https://doi.org/10.1124/mol.116.107730
  • You have access
    Advances in Hypoxia-Mediated Mechanisms in Hepatocellular Carcinoma
    Xin Xin Xiong, Xin Yao Qiu, Dian Xing Hu and Xiao Qian Chen
    Molecular Pharmacology September 2017, 92 (3) 246-255; DOI: https://doi.org/10.1124/mol.116.107706
  • You have access
    Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNFα in Vascular Endothelial Cells through a PXR-Dependent Mechanism
    Shaolan Wang, Xinya Xie, Ting Lei, Kang Zhang, Baochang Lai, Zihui Zhang, Youfei Guan, Guangmei Mao, Lei Xiao and Nanping Wang
    Molecular Pharmacology September 2017, 92 (3) 256-264; DOI: https://doi.org/10.1124/mol.116.108100
  • You have access
    GABABR-Induced EGFR Transactivation Promotes Migration of Human Prostate Cancer Cells
    Shuai Xia, Cong He, Yini Zhu, Suyun Wang, Huiping Li, Zhongling Zhang, Xinnong Jiang and Jianfeng Liu
    Molecular Pharmacology September 2017, 92 (3) 265-277; DOI: https://doi.org/10.1124/mol.116.107854
  • You have access
    GRK2 Mediates Arginine Vasopressin-Induced Interleukin-6 Production via Nuclear Factor-κB Signaling Neonatal Rat Cardiac Fibroblast
    Feifei Xu, Shuzhen Sun, Xiaojun Wang, Eran Ni, Lingling Zhao and Weizhong Zhu
    Molecular Pharmacology September 2017, 92 (3) 278-284; DOI: https://doi.org/10.1124/mol.116.107698
  • You have access
    Megakaryocytic Smad4 Regulates Platelet Function through Syk and ROCK2 Expression
    Yanhua Wang, Lirong Jiang, Xi Mo, Yu Lan, Xiao Yang, Xinyi Liu, Jian Zhang, Li Zhu, Junling Liu and Xiaolin Wu
    Molecular Pharmacology September 2017, 92 (3) 285-296; DOI: https://doi.org/10.1124/mol.116.107417

Articles

  • You have access
    Comparative Exploration of the Structure–Activity Space of Cloned α-Like Octopamine Receptors from a Marine and a Terrestrial Arthropod
    Dhwanil A. Dalwadi and John A. Schetz
    Molecular Pharmacology September 2017, 92 (3) 297-309; DOI: https://doi.org/10.1124/mol.117.108456
  • You have access
    A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site
    Ramkumar Rajamani, Sophie Wu, Iyoncy Rodrigo, Mian Gao, Simon Low, Lisa Megson, David Wensel, Rick L. Pieschl, Debra J. Post-Munson, John Watson, David R. Langley, Michael K. Ahlijanian, Linda J. Bristow and James Herrington
    Molecular Pharmacology September 2017, 92 (3) 310-317; DOI: https://doi.org/10.1124/mol.117.108712
  • You have access
    Determination of the Residues in the Extracellular Domain of the Nicotinic α Subunit Required for the Actions of Physostigmine on Neuronal Nicotinic Receptors
    Xiaochun Jin, Allison L. Germann, Daniel J. Shin, Gustav Akk and Joe Henry Steinbach
    Molecular Pharmacology September 2017, 92 (3) 318-326; DOI: https://doi.org/10.1124/mol.117.108894
  • You have access
    The (α4)3(β2)2 Stoichiometry of the Nicotinic Acetylcholine Receptor Predominates in the Rat Motor Cortex
    Kristen E. DeDominicis, Niaz Sahibzada, Thao T. Olson, Yingxian Xiao, Barry B. Wolfe, Kenneth J. Kellar and Robert P. Yasuda
    Molecular Pharmacology September 2017, 92 (3) 327-337; DOI: https://doi.org/10.1124/mol.116.106880
  • You have access
    Pore Polarity and Charge Determine Differential Block of Kir1.1 and Kir7.1 Potassium Channels by Small-Molecule Inhibitor VU590
    Sujay V. Kharade, Jonathan H. Sheehan, Eric E. Figueroa, Jens Meiler and Jerod S. Denton
    Molecular Pharmacology September 2017, 92 (3) 338-346; DOI: https://doi.org/10.1124/mol.117.108472
  • You have access
    Ca2+ Regulation of Cav3.3 T-type Ca2+ Channel Is Mediated by Calmodulin
    Narae Lee, Sua Jeong, Kang-Chang Kim, Jin-Ah Kim, Jin-Yong Park, Ho-Won Kang, Edward Perez-Reyes and Jung-Ha Lee
    Molecular Pharmacology September 2017, 92 (3) 347-357; DOI: https://doi.org/10.1124/mol.117.108530
  • You have access
    Human Arylamine N-Acetyltransferase 1 Is Inhibited by the Dithiocarbamate Pesticide Thiram
    Ximing Xu, Cécile Mathieu, Jérémy Berthelet, Romain Duval, Linh Chi Bui, Florent Busi, Jean-Marie Dupret and Fernando Rodrigues-Lima
    Molecular Pharmacology September 2017, 92 (3) 358-365; DOI: https://doi.org/10.1124/mol.117.108662
  • You have access
    Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression
    Aditya D. Joshi, Ekram Hossain and Cornelis J. Elferink
    Molecular Pharmacology September 2017, 92 (3) 366-374; DOI: https://doi.org/10.1124/mol.117.108878
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 92 (3)
Molecular Pharmacology
Vol. 92, Issue 3
1 Sep 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Special Section on Molecular Pharmacology in China
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics